Sponsor content
2 result(s) found, displaying 1 to 2
-
Australian public assessment report (AusPar)Sephience (sepiapterin) has been approved for the treatment of hyperphenylalaninaemia in adult and paediatric patients with phenylketonuria.
-
PTC Therapeutics Australia Pty Ltd
Regulatory activities for this sponsor.